Hildenbrand, B <br/><br/>
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot study.  [electronic resource] 

 -  The Prostate  Apr 2007 
 - 500-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/pros.20539  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Cancer Vaccines--adverse effects<br/>Dendritic Cells--immunology<br/>Disease Progression<br/>HLA-A2 Antigen--immunology<br/>Humans<br/>Immunotherapy, Adoptive--adverse effects<br/>Injections, Subcutaneous<br/>Interferon-gamma--adverse effects<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Prostate-Specific Antigen--immunology<br/>Prostatic Neoplasms--immunology<br/>Quality of Life